Uncategorized

Nebraska Launches Action Against Deceptive THC Products

This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy of Medicine.

Nebraska Launches Action Against ‘Deceptive’ THC Products

This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy of Medicine. A day long leadership summit focused on retail, investment & policy across New York and North America. Tickets on-sale now – www.cannabisnewyork.live

Nebraska has launched statewide action against retailers selling mislabeled and deceptive THC-containing products.

Attorney General Mike Hilgers launched the action saying the deceptive THC products present a danger to Nebraskans.

Mislabelled THC-containing products, when consumed, inhaled, or otherwise ingested, pose significant health risks to Nebraskans. The state has highlighted that in some cases, products containing delta-8 have been tied to loss of life and that national poison control centers have received thousands of reports tied to these products.

The FDA and DEA have also issued warnings against their use and synthetically produced THCs, including delta-8, remain unlawful or with significant limits on their use.

Attorney General Hilgers stated: “The sale of these deceptive, mislabeled, dangerous products poses a real threat of harm to Nebraskans, especially children. Today’s action is a message to retailers across the state that selling products that threaten Nebraska’s children will not be tolerated.”

The statewide action will include a series of coordinated lawsuits filed across the state, targeting retailers in at least ten jurisdictions.

Lawsuits have already been filed in Platte, Scottsbluff, Hall, Madison, Lancaster, Sarpy, Lincoln, Saline, Keith and Dawes.

Additionally, a series of consumer protection warnings have been issued, including an online video to help educate parents about the dangers of these products.

The Attorney General has asked each court to enjoin the business’ unlawful behaviour, grant appropriate monetary relief for the numerous and repeated violations, and award any other relief warranted by law.

TopicsCannabis productsdelta 8North America

Stephanie Price

Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".

More from Stephanie

Spotted an error, or have a tip? Contact the newsroom.

Up next · Uncategorized

What’s On the Agenda for Business of Cannabis: New York 2025?

Ben Stevens · 14 October 2025

More